Iovance Biotherapeutics Net Tangible Assets

Iovance Biotherapeutics (IOVA) currently reports a net tangible assets of $740M as of June 2026. That compares with $700M in the prior-year period — up 5.4% year over year. Use the charts on this page to explore Iovance Biotherapeutics's net tangible assets history and peer comparisons.

Iovance Biotherapeutics's net tangible assets increased from $700M to $740M — a 5.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Iovance Biotherapeutics reported $740M in net tangible assets as of June 2026. That compares with $700M in the prior-year period — up 5.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $740M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Iovance Biotherapeutics, and consider following IOVA for alerts when major investors trade the stock.

Iovance Biotherapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $740M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IOVA with unrelated industries.